Obstetrics & Gynecology Doctors in Portsmouth, OH Accepting Medicare

10 Obstetrics & Gynecology doctors found. Showing 1 - 10

Fred Courtney Iii, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1735 27th St, Waller Building, Suite 202, Portsmouth, OH 45662 Phone: 740-356-2496    Fax: 740-356-6334

Dr. Jennifer D Roberts, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1735 27th St Ste 206a, Portsmouth, OH 45662 Phone: 740-353-3196    Fax: 740-353-1298

Dr. Ryan Francis Sandlin, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1729 27th St, Portsmouth, OH 45662 Phone: 740-354-1434    Fax: 740-356-1261

Dr. Gregory Karasik, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1735 27th St Ste 202, Portsmouth, OH 45662 Phone: 740-356-2496    Fax: 740-356-6334

Dr. John S Temponeras, MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1004 24th Street, Portsmouth, OH 45662 Phone: 740-354-2900    Fax: 740-353-8617

Dr. Arrika J Mains, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1735 27th St Ste 202, Portsmouth, OH 45662 Phone: 740-356-2496    Fax: 740-356-6334

Mrs. Carolyn Michelle Arnett, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1735 27th St Ste 202, Portsmouth, OH 45662 Phone: 740-356-2496    Fax: 740-356-6334

Dr. Darren Chad Adams, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1735 27th St Ste 202, Portsmouth, OH 45662 Phone: 740-356-2496    Fax: 740-356-6334

Dr. Yong Duck Song, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1611 27th St, Ste 204 Bldg J, Portsmouth, OH 45662 Phone: 740-353-3196    Fax: 740-353-1258

Allison Hamilton Bentley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1735 27th St Ste 202, Portsmouth, OH 45662 Phone: 740-356-2496    Fax: 740-356-6334

News Archive

Jennerex, Transgene enter partnership to develop JX-594 product for tumor treatment

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States (CIS) and the Middle East.

Study investigates association between preterm birth and later retinal detachment

Children born extremely prematurely have up to a 19 times greater risk of retinal detachment later in life than peers born at term, according to a Swedish study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology.

U of A researcher discovers new vaccine against HCV

A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, who led the team that discovered the hepatitis C virus in 1989, announced his findings at the Canada Excellence Research Chairs Summit in Vancouver this afternoon. Currently, there are no vaccines against the disease available.

GOP probe Sebelius' fundraising for health law outreach

Congressional Republicans want to know whom she contacted and what other HHS officials are involved, while Sen. Lamar Alexander said he would ask the Government Accountability Office to investigate. A Sebelius spokesman said her actions were legal, and that she had not solicited pharmaceutical and insurance companies regulated by the agency.

Athera receives support from FP7 for development of fully human antibody PC-mAb

Athera Biotechnologies AB today announced that future development costs of its fully human antibody PC-mAb up until proof-of-concept will be co-funded by the European Union's Seventh Framework Programme for Research (FP7) through a collaborative research grant. Karolinska Development AB owns 65% of Athera Biotechnologies AB.

Read more Medical News

› Verified 4 days ago